<div class="js-c19-feed" data-post-type="document" id="c19-feed-anchor"><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000137308-witness-statement-on-behalf-of-clinically-vulnerable-families/" class="d-inline-block">INQ000137308 - Witness statement on behalf of Clinically Vulnerable Families</a></h2>
                      <p></p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000176766-2014-nra-chapter-4-hazards-full-assessments-scenario-h24-emerging-infectious-diseases-pp-130-134/" class="d-inline-block">INQ000176766 - 2014 NRA - Chapter 4 - Hazards - Full Assessments - Scenario H24 - Emerging infectious diseases (pp.130-134)</a></h2>
                      <p>2014 NRA - Chapter 4 - Hazards - Full Assessments - Scenario H24 - Emerging infectious diseases (pp.130-134)</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000176765-2014-nra-chapter-4-hazards-full-assessments-scenario-h23-influenza-type-disease-pandemic-pp-122-129/" class="d-inline-block">INQ000176765 - 2014 NRA - Chapter 4 - Hazards - Full Assessments - Scenario H23 - Influenza type disease (pandemic) (pp.122-129)</a></h2>
                      <p>2014 NRA - Chapter 4 - Hazards - Full Assessments - Scenario H23 - Influenza type disease (pandemic) (pp.122-129)</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000185135-document-by-the-cabinet-office-regarding-national-security-risk-assessment-annex-b-full-scenario-assessments-emerging-infectious-disease-r97-dhsc-dated-2019/" class="d-inline-block">INQ000185135 - Document by the Cabinet Office, regarding National Security Risk Assessment - Annex B - Full Scenario Assessments - Emerging Infectious Disease - R97 - DHSC, dated 2019</a></h2>
                      <p>Document by the Cabinet Office, regarding National Security Risk Assessment - Annex B - Full Scenario Assessments - Emerging Infectious Disease - R97 - DHSC, dated 2019</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000176770-2016-nra-annex-a-detailed-risk-assessments-part-i-hazards-scenario-h23-pandemic-influenza-pp-139-150/" class="d-inline-block">INQ000176770 - 2016 NRA - Annex A - Detailed risk assessments Part I (Hazards) - Scenario H23 - Pandemic Influenza (pp.139-150)</a></h2>
                      <p>2016 NRA - Annex A - Detailed risk assessments Part I (Hazards) - Scenario H23 - Pandemic Influenza (pp.139-150)</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000188716-second-witness-statement-of-roger-hargreaves-director-of-the-ccs-in-the-cabinet-office-for-the-grenfell-tower-inquiry-dated-28-06-2022/" class="d-inline-block">INQ000188716 - Second Witness Statement of Roger Hargreaves, Director of the CCS in the Cabinet Office, for the Grenfell Tower Inquiry, dated 28/06/2022</a></h2>
                      <p>Second Witness Statement of Roger Hargreaves, Director of the CCS in the Cabinet Office, for the Grenfell Tower Inquiry, dated 28/06/2022</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000176776-2019-nsra-annex-b-full-scenario-assessments-scenario-r95-influenza-type-disease-pandemic-pp-587-599/" class="d-inline-block">INQ000176776 - 2019 NSRA - Annex B - Full Scenario Assessments - Scenario R95 - Influenza-type Disease Pandemic (pp.587-599)</a></h2>
                      <p>2019 NSRA - Annex B - Full Scenario Assessments - Scenario R95 - Influenza-type Disease Pandemic (pp.587-599)</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000147772-2022-nsra-main-summary/" class="d-inline-block">INQ000147772 - 2022 NSRA - Main Summary</a></h2>
                      <p>2022 NSRA - Main Summary</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000148410-witness-statement-on-behalf-of-medact/" class="d-inline-block">INQ000148410 - Witness statement on behalf of Medact</a></h2>
                      <p>Witness statement on behalf of Medact</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div><div class="row m-0 mb-1 px-1 border">
                    <div class="col-12 col-md-7 c19-feed__item px-1 py-2">
                      <h2 class="heading-sm"><a href="https://covid19.public-inquiry.uk/documents/inq000239420-witness-statement-of-gillian-russell/" class="d-inline-block">INQ000239420 - Witness Statement of Gillian Russell</a></h2>
                      <p>Witness Statement of Gillian Russell</p>
                    </div>
                    <div class="col-12 col-md-5 c19-feed__item px-1 pb-2 pt-md-2">
                      <ul class="list-reset meta flow-content--sm">
                      <li><span class="label">Type: </span>Evidence</li><li><span class="label">Module: </span>Module 1</li>
                      </ul>
                    </div>
                  </div></div>